StockMacro
Menu

cbdMD

$0.36 -53% in 6 monthsMarket cap $4.8M

YCBD on XASE, Materials, cbdMD, Inc., job postings

Measures activity, not value. Not investment advice.

Revenue rose 10% to $20.9M but free cash flow was negative $2.4M while shares fell 53% in six months.

  • Watch1 completed acquisition or disposal in the last 90 days

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Jun 2026

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Industry
Perfumes, cosmetics & other toilet preparations (Materials)
Employees
42
Website
cbdmd.com
Listed
NYSE American, US
Last results
25 Nov 2025
Next results
no estimate
Revenue and net income per quarter. Quarter to 30 Jun 2026: revenue $5.6M, net loss $1.1M.
Quarter to 31 Dec 2021: revenue $9.3M, net income -$19.2MQuarter to 31 Dec 2021: revenue $9.3M, net income -$19.2MQuarter to 31 Mar 2022: revenue $9.6M, net income -$4.7MQuarter to 31 Mar 2022: revenue $9.6M, net income -$4.7MQuarter to 30 Jun 2022: revenue $8.9M, net income -$31.6MQuarter to 30 Jun 2022: revenue $8.9M, net income -$31.6MQuarter to 30 Sep 2022: revenue $8.4M, net income -$14.6MQuarter to 30 Sep 2022: revenue $8.4M, net income -$14.6MQuarter to 31 Dec 2022: revenue $6.2M, net income -$4.0MQuarter to 31 Dec 2022: revenue $6.2M, net income -$4.0MQuarter to 31 Mar 2023: revenue $6.6M, net income -$1.3MQuarter to 31 Mar 2023: revenue $6.6M, net income -$1.3MQuarter to 30 Jun 2023: revenue $6.5M, net income -$1.8MQuarter to 30 Jun 2023: revenue $6.5M, net income -$1.8MQuarter to 30 Sep 2023: revenue $5.8M, net income -$15.9MQuarter to 30 Sep 2023: revenue $5.8M, net income -$15.9MQuarter to 31 Dec 2023: revenue $5.4M, net income -$997KQuarter to 31 Dec 2023: revenue $5.4M, net income -$997KQuarter to 31 Mar 2024: revenue $4.8M, net income -$3.0MQuarter to 31 Mar 2024: revenue $4.8M, net income -$3.0MQuarter to 30 Jun 2024: revenue $5.2M, net income $460KQuarter to 30 Jun 2024: revenue $5.2M, net income $460KQuarter to 30 Sep 2024: revenue $4.6M, net income -$153KQuarter to 30 Sep 2024: revenue $4.6M, net income -$153KQuarter to 31 Dec 2024: revenue $5.1M, net income $15KQuarter to 31 Dec 2024: revenue $5.1M, net income $15KQuarter to 31 Mar 2025: revenue $4.7M, net income -$481KQuarter to 31 Mar 2025: revenue $4.7M, net income -$481KQuarter to 30 Jun 2025: revenue $4.6M, net income -$895KQuarter to 30 Jun 2025: revenue $4.6M, net income -$895KQuarter to 30 Sep 2025: revenue $4.7M, net income -$680KQuarter to 30 Sep 2025: revenue $4.7M, net income -$680KQuarter to 31 Dec 2025: revenue $5.0M, net income -$283KQuarter to 31 Dec 2025: revenue $5.0M, net income -$283KQuarter to 31 Mar 2026: revenue $5.6M, net income -$798KQuarter to 31 Mar 2026: revenue $5.6M, net income -$798KQuarter to 30 Jun 2026: revenue $5.6M, net income -$1.1MQuarter to 30 Jun 2026: revenue $5.6M, net income -$1.1M
31 Dec 2021RevenueNet incomeNet losstallest bar $31.6M30 Jun 2026
See the numbers
Quarter toRevenueNet income
30 Jun 2026$5.6M-$1.1M
31 Mar 2026$5.6M-$798K
31 Dec 2025$5.0M-$283K
30 Sep 2025$4.7M-$680K
30 Jun 2025$4.6M-$895K
31 Mar 2025$4.7M-$481K
31 Dec 2024$5.1M$15K
30 Sep 2024$4.6M-$153K
30 Jun 2024$5.2M$460K
31 Mar 2024$4.8M-$3.0M
31 Dec 2023$5.4M-$997K
30 Sep 2023$5.8M-$15.9M
30 Jun 2023$6.5M-$1.8M
31 Mar 2023$6.6M-$1.3M
31 Dec 2022$6.2M-$4.0M
30 Sep 2022$8.4M-$14.6M
30 Jun 2022$8.9M-$31.6M
31 Mar 2022$9.6M-$4.7M
31 Dec 2021$9.3M-$19.2M
Fundamentals, 12 months to 30 Jun 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $20.9M $19.0M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +10% +5.9%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$2.9M -$1.5M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). – –
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 57.7% 61.2% 61.6%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -13.9% -9.4% 7.8%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -13.8% -8.0% 4.4%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -40.3% 9.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$2.4M -$1.2M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $2.1M $1.1M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $7K –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$2.1M (net cash) –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.00 0.53
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $0.73
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 37.7
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.19 2.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 0.09 1.7
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 0.49 3.0

Latest = 12 months to 30 Jun 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
cbdMDYCBD (this company) $4.8Mloss0.19+10%-13.8%
Caring BrandsCABR $7.6Mloss–––
AXIL BrandsAXIL $29.1M10.50.97+10%9.3%
United-GuardianUG $33.8M10.82.7+24%25.2%
SenesTechSNES $4.7Mloss1.7+21%-275%
Gulf ResourcesGURE $5.0Mloss0.14+71%-13.1%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-3.7%

26 13F filers vs 27

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

7.4%

826K shares held by 13F filers (30 Sep 2026) of 11.2M outstanding (13 Aug 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

4.3%

483K shares sold short (30 Oct 2026) of 11.2M outstanding (13 Aug 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

7.4

483K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-12%

546K shares sold short in the report before, 483K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

29%

29% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 41%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

3

3 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

3 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $0.36 on 20 Nov 2026, -29% over 12 months (12-month range $0.35 to $2.27)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $1.3M in the last 12 months (the 12 months before: $0).
Revenue per quarter. Revenue $5.6M in the latest quarter, +21% on a year earlier.
Capital spending per quarter. Capital spending $18K in the latest quarter, +1125% on a year earlier.
Institutional holders (13F filers). 26 13F filers reported holding it in the latest 13F quarter, +37% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
4 Nov 20268-K and other filingsCompleted an acquisition or asset sale
1 Apr 20268-K and other filingsDirector or officer change
1 Apr 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
20 Feb 20268-K and other filingsRegistered new securities for sale (S-1)
22 Jan 20268-K and other filingsRegistered new securities for sale (S-1)
2 Jan 20268-K and other filingsRegistered new securities for sale (S-1)
30 Dec 2025Sharp changeShort interest spike: short interest spike, 4.0M vs usual 257K (2025-12-15); 18.4x the same period a year earlier
22 Dec 20258-K and other filingsRegistered new securities for sale (S-1)
28 Nov 20258-K and other filingsDirector or officer change
28 Nov 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 Nov 20258-K and other filingsRegistered new securities for sale (S-1)
14 Oct 2025Sharp changeShort interest spike: short interest spike, 2.4M vs usual 200K (2025-09-30); 13.1x the same period a year earlier
13 May 2025Sharp changeShort interest spike: short interest spike, 823K vs usual 189K (2025-04-30); 4.5x the same period a year earlier
29 Apr 2025Sharp changeShort interest spike: short interest spike, 616K vs usual 189K (2025-04-15); 2.7x the same period a year earlier
18 Feb 2025Sharp changeShort interest spike: short interest spike, 559K vs usual 189K (2025-01-31); 2.0x the same period a year earlier
3 Jan 20258-K and other filingsDelisting notice or listing transfer
23 Dec 20248-K and other filingsDirector or officer change
23 Dec 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
26 Aug 20248-K and other filingsDelisting notice or listing transfer
7 Jun 20248-K and other filingsDelisting notice or listing transfer
2 Apr 20248-K and other filingsDirector or officer change
2 Apr 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Mar 20248-K and other filingsRegistered new securities for sale (S-1)
15 Feb 20248-K and other filingsRegistered new securities for sale (S-1)
13 Mar 20238-K and other filingsRegistered new securities for sale (S-1)
2 Mar 20238-K and other filingsDirector or officer change
2 Mar 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
3 Jun 20228-K and other filingsDirector or officer change
17 May 20228-K and other filingsDirector or officer change
17 May 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Jan 20228-K and other filingsDirector or officer change
7 Jan 20228-K and other filingsDirector or officer change
3 Dec 20218-K and other filingsDirector or officer change
Insider net buying (open market)
Month from 1 May 2023: $10K published
Month from 1 Dec 2025: -$1.3M published
Revenue per quarter
Quarter ended 30 Sep 2021: $9.8M, -16% on a year earlier; public on 18 Dec 2021
Quarter ended 31 Dec 2021: $9.3M, -24% on a year earlier; public on 11 Feb 2022
Quarter ended 31 Mar 2022: $9.6M, -18% on a year earlier; public on 14 May 2022
Quarter ended 30 Jun 2022: $8.9M, -16% on a year earlier; public on 12 Aug 2022
Quarter ended 30 Sep 2022: $8.4M, -14% on a year earlier; public on 16 Dec 2022
Quarter ended 31 Dec 2022: $6.2M, -33% on a year earlier; public on 14 Feb 2023
Quarter ended 31 Mar 2023: $6.6M, -32% on a year earlier; public on 16 May 2023
Quarter ended 30 Jun 2023: $6.5M, -27% on a year earlier; public on 11 Aug 2023
Quarter ended 30 Sep 2023: $5.8M, -32% on a year earlier; public on 23 Dec 2023
Quarter ended 31 Dec 2023: $5.4M, -14% on a year earlier; public on 14 Feb 2024
Quarter ended 31 Mar 2024: $4.8M, -27% on a year earlier; public on 16 May 2024
Quarter ended 30 Jun 2024: $5.2M, -20% on a year earlier; public on 15 Aug 2024
Quarter ended 30 Sep 2024: $4.6M, -21% on a year earlier; public on 19 Dec 2024
Quarter ended 31 Dec 2024: $5.1M, -4.9% on a year earlier; public on 14 Feb 2025
Quarter ended 31 Mar 2025: $4.7M, -1.4% on a year earlier; public on 16 May 2025
Quarter ended 30 Jun 2025: $4.6M, -11% on a year earlier; public on 15 Aug 2025
Quarter ended 30 Sep 2025: $4.7M, +3.6% on a year earlier; public on 20 Dec 2025
Quarter ended 31 Dec 2025: $5.0M, -1.9% on a year earlier; public on 18 Feb 2026
Quarter ended 31 Mar 2026: $5.6M, +19% on a year earlier; public on 15 May 2026
Quarter ended 30 Jun 2026: $5.6M, +21% on a year earlier; public on 14 Aug 2026
Capital spending per quarter
Quarter ended 30 Sep 2021: $30K; public on 18 Dec 2021
Quarter ended 31 Dec 2021: $231K, +148% on a year earlier; public on 11 Feb 2022
Quarter ended 31 Mar 2022: $143K, +7.1% on a year earlier; public on 14 May 2022
Quarter ended 30 Jun 2022: $88K, +4.0% on a year earlier; public on 12 Aug 2022
Quarter ended 30 Sep 2022: $226K, +644% on a year earlier; public on 16 Dec 2022
Quarter ended 31 Dec 2022: $177K, -23% on a year earlier; public on 14 Feb 2023
Quarter ended 30 Jun 2023: $102K, +16% on a year earlier; public on 11 Aug 2023
Quarter ended 30 Sep 2023: $120K, -47% on a year earlier; public on 23 Dec 2023
Quarter ended 31 Dec 2023: $185K, +4.1% on a year earlier; public on 14 Feb 2024
Quarter ended 30 Sep 2024: $10K, -92% on a year earlier; public on 19 Dec 2024
Quarter ended 31 Dec 2024: $164K, -11% on a year earlier; public on 14 Feb 2025
Quarter ended 31 Mar 2025: $16K; public on 16 May 2025
Quarter ended 30 Jun 2025: $1K; public on 15 Aug 2025
Quarter ended 30 Sep 2025: $3K, -72% on a year earlier; public on 20 Dec 2025
Quarter ended 31 Dec 2025: $165K, +0.3% on a year earlier; public on 18 Feb 2026
Quarter ended 31 Mar 2026: $6K, -63% on a year earlier; public on 15 May 2026
Quarter ended 30 Jun 2026: $18K, +1125% on a year earlier; public on 14 Aug 2026
Institutional holders (13F filers)
31 Dec 2021 report: 50; public on 14 Feb 2022
31 Mar 2022 report: 52; public on 16 May 2022
30 Jun 2022 report: 53; public on 15 Aug 2022
30 Sep 2022 report: 47; public on 14 Nov 2022
31 Dec 2022 report: 43; public on 14 Feb 2023
31 Mar 2023 report: 43; public on 15 May 2023
30 Jun 2023 report: 18; public on 14 Aug 2023
30 Sep 2023 report: 21; public on 14 Nov 2023
31 Dec 2023 report: 24; public on 14 Feb 2024
31 Mar 2024 report: 19; public on 15 May 2024
30 Jun 2024 report: 22; public on 14 Aug 2024
30 Sep 2024 report: 22; public on 14 Nov 2024
31 Dec 2024 report: 19; public on 14 Feb 2025
31 Mar 2025 report: 24; public on 15 May 2025
30 Jun 2025 report: 17; public on 14 Aug 2025
30 Sep 2025 report: 19; public on 14 Nov 2025
31 Dec 2025 report: 25; public on 17 Feb 2026
31 Mar 2026 report: 25; public on 15 May 2026
30 Jun 2026 report: 27; public on 14 Aug 2026
30 Sep 2026 report: 26; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $1.3M (19 Dec 2025), 74× its normal reading; higher than 80% of its own history.
  • Insider net buying (open market): Insiders sold a net $1.3M in the last 12 months (the 12 months before: $0).
  • Revenue per quarter: Revenue $5.6M in the latest quarter, +21% on a year earlier.
  • Capital spending per quarter: Capital spending $18K in the latest quarter, +1125% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 23 insider trades

No trades in the last 90 days; the latest was filed 19 Dec 2025. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
19 Dec 2025Clark R. Crosnoe10% ownerSell550,701$2.31$1.3MForm 4
5 May 2023Thomas Ronan KennedyInterim CEO and CFOBuy5,000$2.10$10KForm 4
25 Aug 2021Thomas Ronan KennedyCFO & COOBuy7,400$2.04$15KForm 4
26 Jul 2021John J Wiesehan IIIChief Revenue OfficerBuy161,550Not filedNot filedForm 4
12 Mar 2021Martin A. SumichrastChairman & CO-CEOSell125,000$3.98$498KForm 4
3 Mar 2021William F Raines IIIDirectorSell20,000$4.04$81KForm 4
23 Feb 2021Not namedCO-CEO, President, DirectorSell125,000$4.25$531KForm 4
19 Feb 2021Martin A. SumichrastChairman & CO-CEOSell395,600$4.44$1.8MForm 4

26 institutions reported shares at the end of Q3 2026, 7% of the shares outstanding; 3 opened a position, 5 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
CSS LLC138K1.23%$62KNo change
Vanguard Capital Management LLC120K1.07%$54KNo change
HRT Financial LP98K0.87%New+98K
Citadel Advisors LLC93K0.83%$42KNew+93K
Chapin Davis, Inc.81K0.73%$37KNo change
Alesco Advisors, LLC, An ESL Co69K0.61%$31KNo change
Vanguard Fiduciary Trust Co47K0.42%$21KNo change
Jane Street Group, LLC45K0.40%$20K-9,378-17%
Chicago Partners Investment Group LLC37K0.33%$14K-41K-52%
Virtu Financial LLC36K0.32%+25K+243%

Company events

All 66 company events

In 12 months: 4 share registrations, 3 major agreements, 2 director or officer changes, 1 completed deal. Results releases and routine reports are left out.

FiledWhat happenedSource
4 Nov 2026Completed an acquisition or asset saleSame filing: took on new debt, sold shares privately8-K
2 Sep 2026Signed a major agreementSame filing: changed its bylaws or fiscal year8-K
20 May 2026Signed a major agreementSame filing: took on new debt8-K
1 Apr 2026Director or officer changeSame filing: shareholder vote results8-K
19 Feb 2026Registered new securities for sale (S-1)S-1/A
22 Jan 2026Registered new securities for sale (S-1)S-1
13 Jan 2026Signed a major agreementSame filing: sold shares privately8-K
2 Jan 2026Registered new securities for sale (S-1)S-1

The 5 newest of 44 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 4 Nov 2026Filings record

    Completed an acquisition or asset sale

  2. 1 Apr 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  3. 1 Apr 2026Filings record

    Director or officer change

  4. 20 Feb 2026Filings record

    Registered new securities for sale (S-1) (dated 19 Feb 2026)

  5. 22 Jan 2026Filings record

    Registered new securities for sale (S-1)

  6. 2 Jan 2026Filings record

    Registered new securities for sale (S-1)

  7. 25 Dec 2025Short interest and volume change

    had 4.0M shares sold short in the 15 Dec 2025 report, 18× the same report last year.

    Same report last year: 216K; its normal report is 257K.

    See the evidence
    This period
    4.0M (the 15 Dec 2025 report)
    Normal report (median of 24 earlier)
    257K
    Typical spread (median absolute deviation)
    191K
    How far from its usual level
    +13.1
    Same report last year
    216K
    History used
    2,406 days
    2024-12-13: 216K2024-12-31: 285K2025-01-15: 474K2025-01-31: 559K2025-02-14: 460K2025-02-28: 485K2025-03-14: 433K2025-03-31: 444K2025-04-15: 616K2025-04-30: 823K2025-05-15: 38K2025-05-30: 109K2025-06-13: 75K2025-06-30: 65K2025-07-15: 42K2025-07-31: 57K2025-08-15: 68K2025-08-29: 86K2025-09-15: 87K2025-09-30: 2.4M2025-10-15: 399K2025-10-31: 230K2025-11-14: 134K2025-11-28: 727K2025-12-15: 4.0M
    the 15 Dec 2025 report24 earlier reportsnormal: 257K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 22 Dec 2025Filings record

    Registered new securities for sale (S-1)

  9. 28 Nov 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  10. 28 Nov 2025Filings record

    Director or officer change

  11. 7 Nov 2025Filings record

    Registered new securities for sale (S-1)

  12. 10 Oct 2025Short interest and volume change

    had 2.4M shares sold short in the 30 Sep 2025 report, 13× the same report last year.

    Same report last year: 184K; its normal report is 200K.

    See the evidence
    This period
    2.4M (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    200K
    Typical spread (median absolute deviation)
    133K
    How far from its usual level
    +11.2
    Same report last year
    184K
    History used
    2,330 days
    2024-09-30: 184K2024-10-15: 162K2024-10-31: 281K2024-11-15: 206K2024-11-29: 193K2024-12-13: 216K2024-12-31: 285K2025-01-15: 474K2025-01-31: 559K2025-02-14: 460K2025-02-28: 485K2025-03-14: 433K2025-03-31: 444K2025-04-15: 616K2025-04-30: 823K2025-05-15: 38K2025-05-30: 109K2025-06-13: 75K2025-06-30: 65K2025-07-15: 42K2025-07-31: 57K2025-08-15: 68K2025-08-29: 86K2025-09-15: 87K2025-09-30: 2.4M
    the 30 Sep 2025 report24 earlier reportsnormal: 200K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 10 May 2025Short interest and volume change

    had 823K shares sold short in the 30 Apr 2025 report, 4.5× the same report last year.

    Same report last year: 184K; its normal report is 189K.

    See the evidence
    This period
    823K (the 30 Apr 2025 report)
    Normal report (median of 24 earlier)
    189K
    Typical spread (median absolute deviation)
    40K
    How far from its usual level
    +10.6
    Same report last year
    184K
    History used
    2,177 days
    2024-04-30: 184K2024-05-15: 158K2024-05-31: 164K2024-06-14: 142K2024-06-28: 150K2024-07-15: 140K2024-07-31: 158K2024-08-15: 146K2024-08-30: 159K2024-09-13: 153K2024-09-30: 184K2024-10-15: 162K2024-10-31: 281K2024-11-15: 206K2024-11-29: 193K2024-12-13: 216K2024-12-31: 285K2025-01-15: 474K2025-01-31: 559K2025-02-14: 460K2025-02-28: 485K2025-03-14: 433K2025-03-31: 444K2025-04-15: 616K2025-04-30: 823K
    the 30 Apr 2025 report24 earlier reportsnormal: 189K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 26 Apr 2025Short interest and volume change

    had 616K shares sold short in the 15 Apr 2025 report, 2.7× the same report last year.

    Same report last year: 226K; its normal report is 189K.

    See the evidence
    This period
    616K (the 15 Apr 2025 report)
    Normal report (median of 24 earlier)
    189K
    Typical spread (median absolute deviation)
    38K
    How far from its usual level
    +7.6
    Same report last year
    226K
    History used
    2,162 days
    2024-04-15: 226K2024-04-30: 184K2024-05-15: 158K2024-05-31: 164K2024-06-14: 142K2024-06-28: 150K2024-07-15: 140K2024-07-31: 158K2024-08-15: 146K2024-08-30: 159K2024-09-13: 153K2024-09-30: 184K2024-10-15: 162K2024-10-31: 281K2024-11-15: 206K2024-11-29: 193K2024-12-13: 216K2024-12-31: 285K2025-01-15: 474K2025-01-31: 559K2025-02-14: 460K2025-02-28: 485K2025-03-14: 433K2025-03-31: 444K2025-04-15: 616K
    the 15 Apr 2025 report24 earlier reportsnormal: 189K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  15. 12 Feb 2025Short interest and volume change

    had 559K shares sold short in the 31 Jan 2025 report, 2.0× the same report last year.

    Same report last year: 277K; its normal report is 189K.

    See the evidence
    This period
    559K (the 31 Jan 2025 report)
    Normal report (median of 24 earlier)
    189K
    Typical spread (median absolute deviation)
    38K
    How far from its usual level
    +6.6
    Same report last year
    277K
    History used
    2,088 days
    2024-01-31: 277K2024-02-15: 272K2024-02-29: 256K2024-03-15: 244K2024-03-28: 369K2024-04-15: 226K2024-04-30: 184K2024-05-15: 158K2024-05-31: 164K2024-06-14: 142K2024-06-28: 150K2024-07-15: 140K2024-07-31: 158K2024-08-15: 146K2024-08-30: 159K2024-09-13: 153K2024-09-30: 184K2024-10-15: 162K2024-10-31: 281K2024-11-15: 206K2024-11-29: 193K2024-12-13: 216K2024-12-31: 285K2025-01-15: 474K2025-01-31: 559K
    the 31 Jan 2025 report24 earlier reportsnormal: 189K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 3 Jan 2025Filings record

    Delisting notice or listing transfer

  17. 23 Dec 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 23 Dec 2024Filings record

    Director or officer change

  19. 26 Aug 2024Filings record

    Delisting notice or listing transfer

  20. 7 Jun 2024Filings record

    Delisting notice or listing transfer

  21. 2 Apr 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  22. 2 Apr 2024Filings record

    Director or officer change

  23. 19 Mar 2024Filings record

    Registered new securities for sale (S-1)

  24. 15 Feb 2024Filings record

    Registered new securities for sale (S-1)

  25. 6 May 2023Insiders record

    Kennedy Thomas Ronan (Interim CEO and CFO) bought 5,000 shares of YCBD ($10,500) (dated 5 May 2023)

  26. 13 Mar 2023Filings record

    Registered new securities for sale (S-1)

  27. 2 Mar 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  28. 2 Mar 2023Filings record

    Director or officer change

  29. 3 Jun 2022Filings record

    Director or officer change

  30. 17 May 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  31. 17 May 2022Filings record

    Director or officer change

  32. 14 Jan 2022Filings record

    Director or officer change

  33. 7 Jan 2022Filings record

    Director or officer change (dated 6 Jan 2022)

  34. 3 Dec 2021Filings record

    Director or officer change

  35. 5 Oct 2021Filings record

    Director or officer change

  36. 26 Aug 2021Insiders record

    Kennedy Thomas Ronan (CFO & COO) bought 7,400 shares of YCBD ($15,096) (dated 25 Aug 2021)

  37. 27 Jul 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  38. 27 Jul 2021Filings record

    Director or officer change

  39. 27 Jul 2021Insiders record

    Wiesehan John J III (Chief Revenue Officer) bought 161,550 shares of YCBD (dated 26 Jul 2021)

  40. 18 May 2021Filings record

    A major agreement ended

Showing the newest 40 of 78 entries; narrow the window or the kind of data to see older ones.

Not listed: 177 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001644903
Ticker
YCBD
Domain
cbdmd.com
Hq location
NC|CHARLOTTE|28273 (1 unverified)
Name
cbdMD, Inc., LEVEL BEAUTY GROUP, INC., Level Brands, Inc.
  • SEC Form 13F institutional holdings270 data points30 Jun 2019 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)208 records14 Sep 2016 to 4 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)682 data points30 Sep 2015 to 13 Aug 2026
  • SEC Form 4 insider transactions23 records, 60 data points22 Feb 2019 to 19 Dec 2025
  • FINRA short interest (twice monthly)537 data points15 May 2019 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)3804 data points1 May 2019 to 20 Nov 2026